1. Mol Cancer:：PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/beta-catenin signaling pathway，2017年，通讯作者
2. Cancer Lett：The biology, function and clinical implications of exosomes in lung cancer，2017年，通讯作者
3. Transl Lung Cancer Res：Pulmonary ground-glass opacity: computed tomography features, histopathology and molecular pathology，2017年，通讯作者
4. Translational lung cancer research：Evaluation of rare but severe immune related adverse effects in PD-1 and PD-L1 inhibitors in non-small cell lung cancer: a meta-analysis，2017年，通讯作者
5. Biomedicine & Pharmacotherapy：RNA sequencing enables systematic identification of platelet transcriptomic alterations in NSCLC patients，2018年，通讯作者
6. Lung Cancer：Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis，2018年，通讯作者
7. J Cell Mol Med：Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.，2018年，通讯作者
8. J Cell Mol Med：Diagnostic and therapeutic value of progastrin-releasing peptide on small-cell lung cancer: A Single-Center Experience in China..，2018年，通讯作者
9. Transl Lung Cancer Res：The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials，2019年，通讯作者
10. Transl Lung Cancer Res：18F-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis of benign pulmonary lesions in sarcoidosis.，2019年，通讯作者
11. Transl Lung Cancer Res：Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis，2019年，通讯作者
12. Transl Lung Cancer Res：Treatment of uncommon mutations in non-small cell lung cancer: new evidence and treatment， 2019年，通讯作者
13. Transl Lung Cancer Res：Irinotecan, topotecan, paclitaxel or docetaxel for second-line treatment of small cell lung cancer: a single-center retrospective study of efficiency comparation and prognosis analysis，2019年，通讯作者
14. J Cell Physiol：Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis，2019年，通讯作者
15. Oncogene：WNT5B exerts oncogenic effects and is negatively regulated by miR-5587-3p in lung adenocarcinoma progression，2020年，通讯作者
16. Free Radic Biol Med：Geranylgeranyl diphosphate synthase 1 knockout ameliorates ventilator-induced lung injury via regulation of TLR2/4-AP-1 signaling，2020年，通讯作者
17. Transl Lung Cancer Res：Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort，2020年，第一作者
18. Transl Lung Cancer Res：Comparison between closed pleural biopsy and medical thoracoscopy for the diagnosis of undiagnosed exudative pleural effusions: a systematic review and meta-analysis，2020年，通讯作者
19. Transl Lung Cancer Res： Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study，2020年，通讯作者
20. Transl Lung Cancer Res：A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia.，2020年，通讯作者
21. Signal Transduct Target Ther：Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways ，2021年，通讯作者
22. Cancer Lett：Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer ，2021年，通讯作者
23. Front Immunol：Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion，2021年，通讯作者
24. Front Immunol：CD39+ Regulatory T cells attenuate lipopolysaccharide-induced acute lung injury via autophagy and the ERK/FOS pathway，2021年，通讯作者
25. Cancer Sci：Pseudogene KRT17P3 drives cisplatin resistance of human NSCLC cells by modulating miR-497-5p/mTOR，2021年，通讯作者
26. Transl Lung Cancer Res：Novel risk scoring system for immune checkpoint inhibitors treatment in non-small cell lung cancer，2021年，通讯作者
27. Transl Lung Cancer Res：Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience，2021年，通讯作者
28. Transl Lung Cancer Res：The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment，2021年，通讯作者
29. Front Oncol：Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer，2022年，通讯作者
Front Immunol：Comprehensive Analysis of the Immune Microenvironment in Checkpoint Inhibitor Pneumonitis，2022年，通讯作者